That's one distasteful way of putting it kp. Another way is that they have injected potential growth into a company that was creaking at the foundations. There is potentially a pot of gold now at the foot of the reenergised rainbow.
Good fortune all holders
News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-19
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
-0.001(1.23%) |
Mkt cap ! $81.90M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.0¢ | 7.9¢ | $133.2K | 1.679M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 575000 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 442878 | 5 |
View Market Depth
| Last trade - 11.43am 01/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |